passive immunity – Page 3 – Communicable Diseases Research

Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation

Review

Published on 2022-06-032023-06-16
Journal: Environmental science and pollution research inter [Category] COVID19(2023년), MERS, SARS,

[키워드] active immunity autoantibodies Autoimmunity COVID-19 passive immunity SARS-CoV-2
[DOI] 10.1007/s11356-022-20984-7 PMC 바로가기 [Article Type] Review

PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together

PK/PD 모델링은 밤라니비맙 단독 또는 밤라니비맙과 에테세비맙을 함께 치료한 후 환자의 SARS-CoV-2 바이러스 부하 감소와 COVID-19 관련 임상 증상의 가속화된 해결을 연결합니다.

Clinical Trial

Published on 2022-06-012022-09-12
Journal: CPT: pharmacometrics & systems pharmacology [Category] COVID19(2023년), SARS, 임상, 진단,

[키워드] accelerated administration bamlanivimab baseline characterized clinical symptom clinical trial coronavirus disease Course COVID-19 COVID-19-related symptom COVID-19-related symptoms decrease demonstrated develop disease driven by Effect eight etesevimab faster Immunity in viral indicated Mild modeling moderate neutralizing monoclonal antibody offer onset of symptoms participant passive immunity Patient patients with COVID-19 Placebo Probability Receptor binding domain reduction in resulting SARS-CoV-2 SARS-CoV-2 viral load severity of symptom statistically significant Symptom symptom resolution symptom severity the spike protein Treatment Viral load viral load reduction while with COVID-19
[DOI] 10.1002/psp4.12784 PMC 바로가기 [Article Type] Clinical Trial

Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity

편집자: 누락된 연결을 탐색할 시간: SARS-CoV-2 감염의 활성화된 혈소판 및 혈소판 세포외 소포에서 숙주의 이질성을 통해 mRNA 기반 백신 또는 감염 유도 다클론 중화 항체 및 수동적 생리학적, 면역염증 및 지혈 반응에 대한 반응 면역

Editorial

Published on 2022-06-012022-09-12
Journal: Transfusion and apheresis science : official journ [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] activated extracellular vesicle heterogeneity Host immuno-inflammatory Infection mRNA-based vaccine neutralizing antibody passive immunity physiological Platelet polyclonal response SARS-COV-2 infection time
[DOI] 10.1016/j.transci.2022.103464 PMC 바로가기 [Article Type] Editorial

Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19

COVID-19의 예방 및 감염 후 치료를 위한 재조합 SARS-CoV-2 RBD 단백질에 대한 IgY 항체의 전임상 평가

Article

Published on 2022-05-102022-09-12
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단,

Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection

Randomized Controlled Trial

Published on 2022-04-012023-07-07
Journal: Transfusion medicine (Oxford, England) [Category] COVID19(2023년),

[키워드] convalescent plasma COVID-19 Ecuador passive immunity SARS-CoV2
[DOI] 10.1111/tme.12851 [Article Type] Randomized Controlled Trial

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2

회복기 인간 면역 혈장 유래 엑소좀에 대한 전임상 연구: SARS-CoV-2에 대한 오믹스 및 항바이러스 특성

Article

Published on 2022-03-242022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, 치료제,

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice

K18-hACE2 형질전환 마우스에서 우려되는 알파, 베타 및 델타 SARS-CoV-2 변이체에 대한 항체 매개 보호 평가

Article

Published on 2022-03-232022-09-11
Journal: Journal of Virology [Category] MERS, SARS, 변종, 진단, 치료법,

[키워드] Alpha Alpha VOC angiotensin angiotensin converting enzyme Beta Brain can be used concern convalescent convalescent plasma COVID-19 COVID-19 pandemic COVID-19 patient Critically ill decrease Delta Delta VOC disease dose Efficacy elevated enzyme evaluate Evaluating hACE2 hcp Human IgG titer immune evasion immunization in vivo model K18 K18-hACE2 K18-hACE2 transgenic mice lethality lung Mediated mice modeling modeling COVID-19 monoclonal antibody Mortality not decreased nucleocapsid nucleocapsid IgG pandemic passive immunity passive immunization polyclonal antibodies polyclonal antibody problem protection RBD Receptor binding domain response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variants serum single dose Strains survival These data transgenic Transgenic mouse Treatment treatment group Vaccine variants variants of concern Viral Viral RNA while
[DOI] 10.1128/jvi.02184-21 PMC 바로가기 [Article Type] Article

Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

Contents

Published on 2022-02-282022-10-28
Journal: Obstetrics and gynecology [Category] COVID-19, COVID19(2023년), SARS,

[키워드] acute respiratory syndrome Anti-RBD antibody anti-RBD IgA Anti-RBD IgG antibody B.1.1.7 B.1.351 Beta Blood Breast breast milk Breastfeeding Cellular immune response cohort study collected controls coronavirus coronavirus disease correlated COVID-19 COVID-19 vaccination Cutoff cytokine D614G domain Dried blood spots driven by enrolled enzyme-linked immunosorbent evaluate expressed first dose Gamma IgG immune response Immunoglobulin Infant Infants interferon-γ lactating women Level milk mother mRNA mRNA-based mRNA-based COVID-19 vaccine mRNA-based vaccine neutralize neutralized neutralizing antibody P.1 passive immunity positive provided RBD reflected SARS-CoV-2 second dose second vaccination Side effects Stool Stool sample tested transfer transferred vaccination Vaccine variant variants of concern were measured were used women
[DOI] 10.1097/AOG.0000000000004661 PMC 바로가기 [Article Type] Contents

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection

Respiratory Infection

Published on 2022-02-132022-10-28
Journal: Thorax [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,

[키워드] age anti-SARS-CoV-2 antibody antiviral drug approach condition COVID-19 COVID-19 pandemic dose effective effort ENhance evaluate Express expressing expression human ACE2 hypothesised immune response Immune status in vivo individuals Infection intranasal joint Laboratory Lentiviral vector Lower respiratory tract mAb mAbs mice monoclonal antibody offer passive immunity Population Prevent Protein pseudotyped raise reagent reduced respiratory infection respond SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccines significantly spike sustained transfer translated Vaccine Vaccines vector VIP viral infection
[DOI] 10.1136/thoraxjnl-2021-217650 PMC 바로가기 [Article Type] Respiratory Infection

Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women

Article

Published on 2022-02-012023-07-07
Journal: Breastfeeding medicine : the official journal of t [Category] COVID19(2023년),

[키워드] beta-coronaviruses Breastfeeding COVID-19 vaccine Infectious diseases passive immunity secretory IgA
[DOI] 10.1089/bfm.2021.0232